Cargando…
Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021
OBJECTIVE: Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19. METHODS: A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, wa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556734/ http://dx.doi.org/10.1016/j.vacune.2021.10.008 |
_version_ | 1784592228378738688 |
---|---|
author | Alvis-Guzman, N. Alvis-Zakzuk, J. Paz-Wilches, J. Fernandez-Mercado, J.C. de la Hoz-Restrepo, F. |
author_facet | Alvis-Guzman, N. Alvis-Zakzuk, J. Paz-Wilches, J. Fernandez-Mercado, J.C. de la Hoz-Restrepo, F. |
author_sort | Alvis-Guzman, N. |
collection | PubMed |
description | OBJECTIVE: Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19. METHODS: A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, was carried. The respondents were the affiliates or their relatives or caregivers. RESULTS: The average age was 85.0 years (SD: 4.5), with no differences between sexes; 3,344 (28.5%) referred a previous diagnostic test for COVID-19 and 73 were positive for an incidence of 622.8 per 100,000 people (95%CI: 491-778). Regarding the attitude with the vaccination against SARS-CoV-2, 1/4 respondents refrained from giving an opinion or was neutral. When the respondent was a relative, the acceptance of the vaccine was 60.4% (95% CI: 59.5-61.3) with differences by gender: men 62.2% (95% CI: 60.8-63.6) and women of 59.2 (95% CI: 58.0-60.3), P < 0.05. When the respondent was the potential recipient of the vaccine, the acceptance of the vaccine was 61.7% (95% CI: 59.4-64.0) and also differed by gender: 70.2% in men (95% CI: 66, 9-73.5) and 55.1% in women (95% CI: 52.0-58.3), P < 0.05. CONCLUSION: The relatively low acceptance of vaccination against COVID-19 in Colombia poses significant challenges to achieve herd immunity that allows control of the pandemic. |
format | Online Article Text |
id | pubmed-8556734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85567342021-11-01 Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 Alvis-Guzman, N. Alvis-Zakzuk, J. Paz-Wilches, J. Fernandez-Mercado, J.C. de la Hoz-Restrepo, F. Vacunas (English Edition) Original OBJECTIVE: Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19. METHODS: A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, was carried. The respondents were the affiliates or their relatives or caregivers. RESULTS: The average age was 85.0 years (SD: 4.5), with no differences between sexes; 3,344 (28.5%) referred a previous diagnostic test for COVID-19 and 73 were positive for an incidence of 622.8 per 100,000 people (95%CI: 491-778). Regarding the attitude with the vaccination against SARS-CoV-2, 1/4 respondents refrained from giving an opinion or was neutral. When the respondent was a relative, the acceptance of the vaccine was 60.4% (95% CI: 59.5-61.3) with differences by gender: men 62.2% (95% CI: 60.8-63.6) and women of 59.2 (95% CI: 58.0-60.3), P < 0.05. When the respondent was the potential recipient of the vaccine, the acceptance of the vaccine was 61.7% (95% CI: 59.4-64.0) and also differed by gender: 70.2% in men (95% CI: 66, 9-73.5) and 55.1% in women (95% CI: 52.0-58.3), P < 0.05. CONCLUSION: The relatively low acceptance of vaccination against COVID-19 in Colombia poses significant challenges to achieve herd immunity that allows control of the pandemic. Published by Elsevier España, S.L.U. 2021 2021-10-30 /pmc/articles/PMC8556734/ http://dx.doi.org/10.1016/j.vacune.2021.10.008 Text en © 2021 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Alvis-Guzman, N. Alvis-Zakzuk, J. Paz-Wilches, J. Fernandez-Mercado, J.C. de la Hoz-Restrepo, F. Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title | Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title_full | Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title_fullStr | Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title_full_unstemmed | Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title_short | Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
title_sort | disposición a recibir la vacuna contra covid-19 en población de 80 y más años en colombia 2021 |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556734/ http://dx.doi.org/10.1016/j.vacune.2021.10.008 |
work_keys_str_mv | AT alvisguzmann disposicionarecibirlavacunacontracovid19enpoblacionde80ymasanosencolombia2021 AT alviszakzukj disposicionarecibirlavacunacontracovid19enpoblacionde80ymasanosencolombia2021 AT pazwilchesj disposicionarecibirlavacunacontracovid19enpoblacionde80ymasanosencolombia2021 AT fernandezmercadojc disposicionarecibirlavacunacontracovid19enpoblacionde80ymasanosencolombia2021 AT delahozrestrepof disposicionarecibirlavacunacontracovid19enpoblacionde80ymasanosencolombia2021 |